genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
News
Drug Discovery
Melanoma Resistance to Checkpoint Therapy Scrutinized with Perturb-CITE-Seq
News
Light-Controlled Clustering of Receptors Acts Like a Signal to Trigger Cellular…
Coronavirus
Five COVID-19 Projects at UCSD Receive $33 million from NIH
OMICs
Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity
OMICs
Changes in the Gut Microbiome Potentially Linked to Alzheimer’s
Insights
All
Trends for 2021
Trends for 2020
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Drug Discovery
Melanoma Resistance to Checkpoint Therapy Scrutinized with Perturb-CITE-Seq
OMICs
Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity
OMICs
Changes in the Gut Microbiome Potentially Linked to Alzheimer’s
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Pfizer
Pfizer
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pfizer
Pfizer, BioNTech Gain Temporary U.K. Authorization for COVID-19 Vaccine
Pfizer
Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B
Pfizer
FDA Set to Authorize Emergency Use of Pfizer/BioNTech COVID-19 Vaccine
Pfizer
Pfizer, Sangamo Report Positive Phase I/II Data for Severe Hemophilia A Gene Therapy
Pfizer
Pfizer, BioNTech Seek Emergency Use Authorization for COVID-19 Vaccine
Pfizer
Pfizer Raises Gene Therapy Stake with $500M Sanford, NC, Expansion
Pfizer
Pfizer, BioNTech COVID-19 Vaccine >90% Effective in Early Phase III Data
Pfizer
Pfizer, BioNTech Begin Phase II/III Trial of COVID-19 Vaccine, Switching Lead...
Pfizer
Pfizer, BioNTech Gain Temporary U.K. Authorization for COVID-19 Vaccine
Pfizer
FDA Grants Pfizer, BioNTech Emergency Use Authorization for COVID-19 Vaccine
Pfizer
Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B
Pfizer
As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19...
Pfizer
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Pfizer
Pfizer, BioNTech Seek Emergency Use Authorization for COVID-19 Vaccine
Pfizer
COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech...
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
